| Patents for C07K 5 - Peptides having up to four amino acids in a fully defined sequence; Derivatives thereof (30,692) |
|---|
| 05/26/1992 | US5116941 Peptide substrates for determination of enzyme activity |
| 05/26/1992 | US5116861 Treatment of Hypertension and Angina Pectoris |
| 05/26/1992 | US5116835 Enzyme-inhibiting urea derivatives of dipeptides, a process for the preparation thereof, agents containing these, and the use thereof |
| 05/26/1992 | US5116730 Amino acid substituted 4-aminophenazones for measuring enzyme activity |
| 05/26/1992 | CA1302005C Aminoacid derivatives as antihypertensives |
| 05/22/1992 | WO1992009556A1 Improved matrix metalloprotease inhibitors |
| 05/22/1992 | CA2096221A1 Matrix metalloprotease inhibitors |
| 05/20/1992 | EP0486478A2 Renin-inhibiting peptides |
| 05/20/1992 | EP0486280A2 Piperidinylcamphorsulfonyl oxytocin antagonists |
| 05/20/1992 | EP0485458A1 Thioacylating reagents and intermediates, thiopeptides, and methods for preparing and using same. |
| 05/20/1992 | CA2055685A1 Hiv protease inhibitors having polyether substituents |
| 05/19/1992 | US5115099 Substrates for determination of enzyme activity and intermediates for synthesis of the substrates as well as process for producing the intermediates |
| 05/19/1992 | US5115098 End-blocked peptides inhibiting binding capacity of gp120 |
| 05/19/1992 | US5114962 New amino acid esters, a process for their preparation, medicaments containing them, and the use thereof |
| 05/19/1992 | US5114953 Peptides |
| 05/19/1992 | US5114927 Hypotensive agents and inhibiting renin |
| 05/19/1992 | US5114926 Tetrapeptide inhibiting the entry into cycle of hemopoietic stem cells processes for its preparation, and its uses |
| 05/19/1992 | US5114925 Renin inhibitors containing the 2-[[(2R,3S)-3-amino-4-cyclohexyl-2-hydroxy-1-butyl]thio)alkanoyl moiety and the corresponding sulfoxide and sulfone derivatives |
| 05/19/1992 | US5114921 Amphiphilic peptides and use thereof |
| 05/19/1992 | CA1301181C2 Oxiranes |
| 05/16/1992 | WO1992008709A1 Meta-substituted phenyl alanine derivatives |
| 05/16/1992 | CA2073776A1 Meta-substituted phenyl alanine derivatives |
| 05/14/1992 | WO1992007956A1 Process for amplifying nucleic acid |
| 05/14/1992 | WO1992007874A1 Pharmaceutically active proteins comprising an active protein and an integrinaffinity sequence |
| 05/14/1992 | WO1992007869A1 Inhibitors and substrates of thrombin |
| 05/14/1992 | WO1992007576A1 Protective four amino acid epitope against plasmodium vivax malaria |
| 05/14/1992 | CA2055024A1 N-phenyl piperidinylcamphorsulfonyl oxytocin antagonists |
| 05/13/1992 | EP0484769A2 Improved process for crystallizing L-alpha-aspartyl-L-phenylalanine methyl ester from the solution |
| 05/13/1992 | EP0484719A2 Tachykinin antagonist |
| 05/12/1992 | US5112953 Radiolabeled proteins for diagnostic or therapeutic use |
| 05/12/1992 | US5112947 Oligopeptides, nootropic agents |
| 05/12/1992 | US5112944 Antitumor agents |
| 05/12/1992 | US5112811 Sdk peptides and therapeutic compositions containing them |
| 05/12/1992 | CA1300807C Heterocyclic derivatives |
| 05/07/1992 | DE4034707A1 New hydroxyethyl-amine and norstatin-type pseudo:peptide(s) |
| 05/06/1992 | EP0483271A1 Peptides containing diamino-glycols as transition-state mimics. |
| 05/06/1992 | CN1060848A Peptide compounds, processes for preparation thereof and pharmaceutical composition comprising same |
| 05/05/1992 | USH1056 Luteinizing hormone-releasing hormone |
| 05/05/1992 | US5110936 Condensation of pyroglutamic acid with ethyl ester of 4-thiazolidinecarboxylic acid |
| 05/05/1992 | US5110799 Inhibition of viral ribonucleotide reductase |
| 05/05/1992 | US5110798 Purine derivatives having pharmacological action |
| 05/05/1992 | US5110797 Neurotropic agents |
| 05/05/1992 | US5110795 Methods and compositions for the treatment of inflammatory bowel diseases and conditions |
| 05/05/1992 | CA1300313C2 Amino acid derivatives |
| 05/03/1992 | CA2054667A1 Cyclopeptides |
| 04/30/1992 | WO1992007265A1 Selective peptide labeling with hydrogen isotopes |
| 04/30/1992 | WO1992006996A1 Peptides containing substituted 1,4-diamines as transition-state inserts |
| 04/30/1992 | WO1992000284A3 Method for forming an amino acid thiohydantoin using an n-substituted ketenimine activator |
| 04/30/1992 | WO1991018866A3 1,4-diamino-2,3-dihydroxybutanes |
| 04/29/1992 | EP0482539A2 Peptide compounds, processes for preparation thereof and pharmaceutical composition comprising the same |
| 04/28/1992 | US5109000 Thiol carboxylic acid derivatives and their use as collagenase inhibitor |
| 04/28/1992 | US5108990 Glutamic acid derivatives |
| 04/28/1992 | US5108890 Chromogenic compounds, processes for the preparation thereof and use thereof as enzyme substrates |
| 04/28/1992 | CA1299813C METHOD OF SEPARATING .alpha.-L-ASPARTYL-L-PHENYLALANINE METHYL ESTER THROUGH CRYSTALLIZATION |
| 04/25/1992 | CA2054097A1 Peptide compounds, processes for preparation thereof and pharmaceutical composition comprising the same |
| 04/23/1992 | CA2053772A1 Benzolactam analogs as antagonists of cck |
| 04/22/1992 | EP0481522A1 Novel mercaptoacetylamide derivatives useful as inhibitors of enkephalinase and ace |
| 04/22/1992 | EP0481311A2 Aminoacid derivatives |
| 04/22/1992 | EP0480969A1 Amino acid analog cck antagonists |
| 04/22/1992 | EP0317573B1 Antipyretic and anti-inflammatory peptides |
| 04/22/1992 | CN1060472A Tripeptide antithrombotic agents |
| 04/22/1992 | CN1016341B Novel spergualin-related compounds and process for producing the same |
| 04/21/1992 | US5106948 Anticarcinogenic agents |
| 04/21/1992 | US5106835 Renin inhibitors |
| 04/19/1992 | CA2053573A1 Amino acid derivatives |
| 04/16/1992 | WO1992006108A1 Peptide compounds of laevorotatory amino acids and ring molecules, and therapeutical applications thereof |
| 04/16/1992 | WO1992006090A1 Epoxysuccinamic acid derivative |
| 04/15/1992 | EP0480071A1 S-(lower fatty acid)-substituted glutathione derivative |
| 04/15/1992 | EP0480061A1 Hepatic disorder inhibitor |
| 04/15/1992 | EP0480060A1 S-(lower fatty acid)-substituted glutathione derivative |
| 04/15/1992 | EP0480044A1 Novel 4h-3,1-benzoxazin-4-one derivative |
| 04/15/1992 | EP0479912A1 Inhibition of the n-end rule pathway in living cells. |
| 04/15/1992 | EP0479910A1 N-SUBSTITUTED CYCLOALKYL AND POLYCYCLOALKYL ALPHA-SUBSTITUTED Trp-Phe- AND PHENETHYLAMINE DERIVATIVES |
| 04/15/1992 | CN1060294A Improved oligosaccharide conjugate vaccines |
| 04/15/1992 | CN1060293A Fibrinogen receptor antagonists |
| 04/14/1992 | US5104852 Administering selenodiglutathione, selenodicysteine or selenodimethionone to the center of a tumor from where it diffuses outwardly |
| 04/14/1992 | CA1298842C Amino acid analogs as cck-antagonists |
| 04/13/1992 | WO1992007270A1 Diagnostic method |
| 04/13/1992 | CA2069417A1 Diagnostic method |
| 04/08/1992 | EP0479489A2 Tripeptide antithrombotic agents |
| 04/08/1992 | EP0479481A2 Fibrinogen receptor antagonists |
| 04/08/1992 | EP0478729A1 Process for manufacturing aspartame from a diketopiperazine and novel intermediates and derivatives therefor. |
| 04/08/1992 | CN1060096A Fibrinogen receptor anlagonists |
| 04/07/1992 | US5102990 Direct radiolabeling of antibodies and other proteins with technetium or rhenium |
| 04/07/1992 | CA1298682C PREPARATION PROCESS OF .alpha.-L-ASPARTYL-L-PHENYL-ALANINE METHYL ESTER OR HYDROHALIDE THEREOF |
| 04/02/1992 | WO1992005190A1 Deoxyhypusyl hydroxylase inhibitors |
| 04/02/1992 | WO1992005179A1 Carboxylic acid esters of rapamycin |
| 04/02/1992 | WO1992005160A1 4-arylsulfonyl-3,4-dihydro-2(1h)-quinoxalinone-1-alkanoic acids, esters, and salts |
| 04/01/1992 | EP0477912A2 Novel N-acyldipeptides, processes for the preparation thereof and pharmaceutical compositions containing the same |
| 04/01/1992 | EP0477508A1 Improved oligosaccharide conjugate vaccines |
| 03/31/1992 | US5101039 Azabicycloamino carboxylic acid intermediates |
| 03/31/1992 | US5100875 Novel peptides having plateler aggregation inhibitory activity |
| 03/31/1992 | US5100874 Collagenase Inhibitors |
| 03/31/1992 | CA1298435C Pentapeptides with cell growth regulatory effects and a process for the preparation thereof |
| 03/31/1992 | CA1298434C Process for the preparation of alpha-l-aspartyl-l- phenylalanine methyl ester |
| 03/31/1992 | CA1298433C Amino acid derivatives |
| 03/31/1992 | CA1298432C PROCESS FOR SEPARATION OF N-PROTECTED- .alpha. L-ASPARTYL- L-PHENYLALANINES |
| 03/29/1992 | CA2051782A1 Aminoesters of rapamycin |
| 03/28/1992 | CA2052057A1 Fibrinogen receptor antagonists |
| 03/25/1992 | EP0476933A1 Neurotrophic peptide derivatives |